Literature DB >> 23007928

C-peptide-stimulated nitric oxide production in a cultured pulmonary artery endothelium is erythrocyte mediated and requires Zn(2+).

Adam W Giebink1, Paul A Vogel, Wathsala Medawala, Dana M Spence.   

Abstract

BACKGROUND: C-peptide has been shown to stimulate the production of nitric oxide (NO) in aortic endothelial cells via activation of endothelial nitric oxide synthase (eNOS) through an increased calcium influx. Here, results obtained using cultured bovine pulmonary artery endothelial cells (bPAECs) suggest that C-peptide does not induce eNOS activation directly in cultured pulmonary artery endothelium. However, C-peptide has been shown to stimulate the release of ATP from erythrocytes, a well-documented stimulus of eNOS activity in the pulmonary endothelium. Therefore, studies were performed to examine if C-peptide can indirectly stimulate NO production in a cultured pulmonary endothelium that is erythrocyte mediated.
METHODS: NO production and free intracellular calcium changes were monitored in immobilized bPAECs using specific intracellular fluorescent probes after stimulation with adenosine triphosphate (ATP), calcium ionophore A23187, or C-peptide. A microfluidic device enabled immobilized bPAECs to interact with flowing erythrocytes in the presence and absence of C-peptide to determine the role of the erythrocyte in C-peptide-stimulated NO production in cultured bPAECs.
RESULTS: ATP and the calcium ionophore stimulate significant increases in both intracellular NO production and influx of free calcium in cultured bPAECs. In contrast, C-peptide, ranging from physiological to above physiological concentrations, was unable to stimulate NO production or calcium influx in the bPAECs. However, when erythrocytes were pre-incubated with a mixture containing physiological concentrations of C-peptide with Zn(2+) and haemodynamically pumped beneath bPAECs cultured on a microfluidic device, an 88.6 ± 7.5% increase in endothelial NO production was observed.
CONCLUSIONS: C-peptide does not affect NO production in bPAECs directly but can impact NO production through an erythrocyte-mediated mechanism. Furthermore, in the absence of Zn(2+), C-peptide does not stimulate this NO production directly or indirectly. These results suggest that C-peptide, in the presence of Zn(2+), may be a determinant in purinergic receptor signalling via its ability to stimulate the release of ATP from erythrocytes.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23007928     DOI: 10.1002/dmrr.2359

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  7 in total

Review 1.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 2.  C-Peptide and its career from innocent bystander to active player in diabetic atherogenesis.

Authors:  Corinna Lebherz; Nikolaus Marx
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

3.  A microfluidic interface for the culture and sampling of adiponectin from primary adipocytes.

Authors:  Leah A Godwin; Jessica C Brooks; Lauren D Hoepfner; Desiree Wanders; Robert L Judd; Christopher J Easley
Journal:  Analyst       Date:  2015-02-21       Impact factor: 4.616

Review 4.  Cardiovascular Diseases and Zinc.

Authors:  Serhan Ozyildirim; Saltuk Bugra Baltaci
Journal:  Biol Trace Elem Res       Date:  2022-06-08       Impact factor: 3.738

5.  Albumin Glycation Affects the Delivery of C-Peptide to the Red Blood Cells.

Authors:  Monica J Jacobs; Morgan K Geiger; Suzanne E Summers; Charles P DeLuca; Kurt R Zinn; Dana M Spence
Journal:  ACS Meas Sci Au       Date:  2022-03-02

Review 6.  Red blood cells in type 1 diabetes and multiple sclerosis and technologies to measure their emerging roles.

Authors:  M Geiger; E Hayter; R S Martin; D Spence
Journal:  J Transl Autoimmun       Date:  2022-08-07

Review 7.  C-Peptide as a Therapy for Type 1 Diabetes Mellitus.

Authors:  Rachel L Washburn; Karl Mueller; Gurvinder Kaur; Tanir Moreno; Naima Moustaid-Moussa; Latha Ramalingam; Jannette M Dufour
Journal:  Biomedicines       Date:  2021-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.